The Brazilian government will soon begin producing antiretrovirals (ARVs) and other pharmaceuticals at a factory in Mozambique, according to a statement from the Brazilian presidency. Officially known as the Mozambican Medications Company (SMM), the plant is the first public institution in the pharmaceutical industry in Africa, and was made possible through a partnership between the governments of Brazil and Mozambique that is expected to benefit about 2.7 million people living with HIV and AIDS in Mozambique. Initially, three antiretroviral drugs will be produced - Lamivudine + Zidovudine, Nevirapine and Ribavirin - totalling 226 million pharmaceutical units per year that will be distributed to patients. Another five drugs will be added to the list in the future. In addition to the antiretrovirals, another 21 types of drugs are scheduled to be produced, including antibiotics, anti-anemias, antihypertensives, anti-inflammatories, hypoglycemiants, diuretics, antiparasitics and corticosteroid drugs. Overall, the factory is expected to produce about 371 million pharmaceutical units per year.
Bibliography
Theme area
Health equity in economic and trade policies, Equity and HIV/AIDS
Title of publication Brazil to produce ARVs in Mozambique
Date of publication
2012 July
Publication type
Electronic Source
Publication details
Publication status
Published
Language
English
Keywords
medicines, Brazil, antiretrovirals, Mozambique, pharmaceutical production, south-south
Abstract
Country
Senegal
Publisher
Panapress